Spiroindolone KAE609 for falciparum and vivax malaria. by White, N, Pukrittayakamee, S, Phyo, A, Rueangweerayut, R, Nosten, F, Jittamala, P, Jeeyapant, A, Jain, J, Lefèvre, G, Li, R, Magnusson, B, Diagana, T, Leong, F

Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria by Rueangweerayut, R, Phyo, A, Uthaisin, C, Poravuth, Y, Binh, T, Tinto, H, Pénali, L, Valecha, N, Tien, N, Abdulla, S, Borghini-Fuhrer, I, Duparc, S, Shin, C, Fleckenstein, L

Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial by Poravuth, Y, Socheat, D, Rueangweerayut, R, Uthaisin, C, Pyae Phyo, A, Valecha, N, Rao, B, Tjitra, E, Purnama, A, Borghini-Fuhrer, I, Duparc, S, Shin, C, Fleckenstein, L

Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. by Osorio, L, Carter, N, Arthur, P, Bancone, G, Gopalan, S, Gupta, S, Noedl, H, Kochar, S, Kochar, D, Krudsood, S, Lacerda, M, Llanos-Cuentas, A, Rueangweerayut, R, Srinivasan, R, Treiber, M, Möhrle, J, Green, J

Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers by Rueangweerayut, R, Bancone, G, Harrell, E, Beelen, A, Kongpatanakul, S, Möhrle, J, Rousell, V, Mohamed, K, Qureshi, A, Narayan, S, Yubon, N, Miller, A, Nosten, F, Luzzatto, L, Duparc, S, Kleim, J, Green, J